학술논문
Evaluation of the safety and effectiveness after switch from adalimumab originator to biosimilar SB5 in patients with inflammatory bowel disease in a real-life setting
Document Type
Article
Author
Source
In: Acta Gastro-Enterologica Belgica . (Acta Gastro-Enterologica Belgica, October-December 2022, 85(4):557-564)
Subject
Language
English
ISSN
17843227